Jeffrey Endsley DO in Muskogee, Oklahoma

Medical School: Oklahoma State University College Of Osteopathic Medicine
Graduation Year: 1991
The Primary Medical Specialty for Jeffrey Endsley DO is listed as: Dermatology
Credentials: DO
Additional Credentials:
Approximate Years of Experience: 33
PAC (PECOS ID)#: 0244337806
NPI #: 1639208937
NPI Created On: 03/04/2007
NPI Last Updated Listed as: 07/08/2007
Primary Taxonomy Code: 207N00000X
License Number:
3027
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Humana
• Blue Cross Blue Shield
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, ENGLISH.

Services and Procedures include:

1. Tangential biopsy of single skin lesion
2. Tangential biopsy of additional skin lesion
3. Shaving of 0.6 centimeters to 1.0 centimeters skin growth of the trunk, arms, or legs
4. Removal of growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs
5. Removal of malignant growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs
6. Removal of malignant growth (2.1 to 3.0 centimeters) of the trunk, arms, or legs
7. Removal of malignant growth (1.1 to 2.0 centimeters) of the scalp, neck, hands, feet, or genitals
8. Removal of malignant growth (0.6 to 1.0 centimeters) of the face, ears, eyelids, nose, or lips
9. Removal of malignant growth (1.1 to 2.0 centimeters) of the face, ears, eyelids, nose, or lips
10. Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs
11. Repair of wound (2.6 to 7.5 centimeters) of neck, hands, feet, and/or genitals
12. Repair of wound (2.5 centimeters or less) of face, ears, eyelids, nose, lips, and/or mouth
13. Repair of wound (2.6 to 5.0 centimeters) of face, ears, eyelids, nose, lips, and/or mouth
14. Destruction of skin growth
15. Destruction of 2-14 skin growths
16. Destruction of 15 or more skin growths
17. Destruction of up to 14 skin growths
18. Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs
19. Destruction of malignant growth (0.6 to 1.0 centimeters) of face, ears, eyelids, nose, lips, or mouth
20. Destruction of malignant growth (1.1 to 2.0 centimeters) of face, ears, eyelids, nose, lips, or mouth